Auph short interest.

AUPH / Aurinia Pharmaceuticals Inc short borrow fee rates are shown in the following table. This table shows the interest rate that must be paid by a short seller of US:AUPH to the lender of that security. This fee is shown as an annual percentage rate (APR).Funds + ETFs. After-Hours Quotes. See All Market Activity->. News + Insights.If you stay in your home long enough, you usually build enough equity that you can sell it for a profit. When you have to sell the property before then or during a downturn in the market, you may need to find out how to short sale a house.Global Coverage. Comprehensive ownership data of US Institutions, Mutual Funds, and ETFs targeting equities and bonds in mature, emerging, and frontier markets. Activist Investor 13D Filings. Beneficial Ownership 13G Filings. Institutional Ownership 13F Filings. Insider 3, 4 and 5 Filings.WebShort Float / Ratio: 13.17% / 8.88: Perf Quarter-4.23%: Sales: 158.85M: P/S: 8.19: EPS this Y: 31.36%: Inst Trans: 9.16%: Short Interest: 17.19M: Perf Half Y-5.03%: Book/sh: 2.73: …

Aurinia ( AUPH) shares have climbed ~59.7% in the year so far despite a ~2% decline over the past 30 days. The stock has added ~5.8% in the post-market with ~1.5M shares changing hands compared to ...These revisions helped boost AUPH's consensus estimate, increasing from -$0.76 to -$0.71 in the past 60 days. Looking at the next fiscal year, 2 estimates have moved upwards while there have been ...In this section, we analyze the short-term loss avoidance of every unplanned, open-market insider sale made in AUPH / Aurinia Pharmaceuticals Inc. A consistent pattern of loss avoidance may suggest that future sale transactions may predict declines in price.

Aurinia Pharma (AUPH) is scheduled to announce Q2 earnings results on Thursday, August 3rd, before market open.The consensus EPS Estimate is -$0.18 (+28.0% Y/Y) and the consensus...Interest Coverage Financials. AUPH's profit margin has increased... subscribe to Premium to read more. Profit Margin Growth Financials. ... AUPH's cash and short-term investments... subscribe to Premium to read more. Debt Coverage Financials. AUPH vs Biotech Stocks. Ticker Market Cap 1d % P/E P/B; AUPH: $1.18B +4.44%-15.53x:

Dec 2, 2021 · Aurinia Pharmaceuticals (AUPH) rose 17% at least partly on some take takeover speculation following comments from Novartis (NVS). Novartis reportedly said during its R&D day earlier... Aurinia Pharma press release (NASDAQ:AUPH): Q3 GAAP EPS of -$0.09 beats by $0.08.; Revenue of $54.52M (-2.3% Y/Y) beats by $16.02M. Achieved European pricing and reimbursement milestone triggering ...Are you a smaller woman looking for a new hairstyle? Short haircuts can be a great way to make a bold statement and show off your features. But with so many options available, it can be hard to know which one is right for you.Aurinia Pharmaceuticals Stock (NASDAQ:AUPH), Short Interest Report. Short interest for Aurinia Pharmaceuticals gives investors a sense of the degree to …

Aurinia Pharma ( NASDAQ: AUPH) is scheduled to announce Q3 earnings results on Thursday, November 2nd, before market open. The consensus EPS Estimate is -$0.17 vs -$0.06 in 3Q22 and the consensus ...

View the latest Aurinia Pharmaceuticals Inc. (AUPH) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Biogen has more recently been seen as a potential acquirer of AUPH after a Stat News report said that Biogen is working with Goldman Sachs to find potential targets for the company. Aurinia ( AUPH ...Overview of financial data and news for Aurinia Pharmaceuticals Inc., Nasdaq:AUPHThe short interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) is 17.19 million shares and it means that shorts have 11.64 day(s) to cover. The consensus price target of analysts on Wall Street is $13.21, which implies an increase of 34.6% to the stock’s current value.Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools. Identify stocks that meet your criteria using seven unique stock screeners.WebAUPH is currently averaging 3,052,205 shares for the last 20 days. Earnings Outlook The Zacks Momentum Style Score also takes into account trends in estimate revisions, in addition to price changes.Thinking about investing in Aurinia Pharmaceuticals because of the upcoming earnings date annual report or stock price forecast? Check out AUPH short interest and earnings date annual report by comparing AUPH insider trading history and institutional ownership breakdown to maximise your investment return on the stock market.

Net amortization of premiums and discounts on short-term investments (8,836) (14) Share-based compensation expense: 33,543 25,398 Write-down of inventory: 916 2,464 Other, net (3,910) 601 Net changes in operating assets and liabilities: Accounts receivable, net (24,463) (26,356) Inventories, net (8,984) (8,458) Prepaid expenses and other ...Short Interest. Most Shorted. Largest Increase. Largest Decrease. ... Cramer said Aurinia Pharmaceuticals Inc. AUPH is a Canadian company that "I don’t really have a lot of confidence in, ...WebAurinia Pharmaceuticals Stock (NASDAQ:AUPH), Short Interest Report. Short interest for Aurinia Pharmaceuticals gives investors a sense of the degree to …Aurinia Pharmaceuticals (AUPH) Short Interest Ratio & Short Volume $8.85 -0.39 (-4.22%) (As of 03:22 PM ET) Compare Today's Range $8.77 $10.05 50-Day Range $7.13 $9.24 52-Week Range $4.07 $12.43 Volume 6.25 million shs Average Volume 2.60 million shs Market Capitalization $1.27 billion P/E Ratio N/A Dividend Yield N/A Price Target $14.00Finding the right furnished short term rental can be a daunting task. With so many options available, it can be difficult to know which one is best for you. Here are some tips to help you make the right choice when selecting a furnished sho...M&A season started earlier this week with TRIL / Pfizer, AUPH is one of the best candidate for the big pharmas. A weird Press Release appeared yesterday morning on different websites, likely fake or at least released to early, about a 35+ acquisition by a big pharma, it was later asked to be removed from Benzinga (but not denied) The short interest

Nursing is an excellent career path if you’re interested in working in the healthcare industry and strive to provide quality care to patients. If you’re short on time or worry that attending a brick-and-mortar school isn’t possible, one alt...Short Interest. Percentage of Shares Shorted 11.97% of the outstanding shares of Aurinia Pharmaceuticals have been sold short. Short Interest Ratio / Days to …

Short Squeeze - Canada; Short Squeeze - Hong Kong; Highest Cost to Borrow; Highest Short Float; Owners Retail Ownership Most Popular Funds Activist Investors Fund Sentiment - World. United States Canada UK Hong Kong Japan Australia New Zealand. Germany Switzerland Spain Poland Netherlands Greece France Ireland Italy Belgium …WebFind the latest Aurinia Pharmaceuticals Inc. (AUPH) stock quote, history, news and other vital information to help you with your stock trading and investing. ... Short Term. 2W - 6W. Mid Term. 6W ...Aurinia Pharmaceuticals ( NASDAQ: AUPH) rose 5% amid speculation the company may be a takeover target after Tuesday's patent settlement with Sun Pharmaceuticals. Aurinia ( AUPH) surged 38% on ...Are you a smaller woman looking for a new hairstyle? Short haircuts can be a great way to make a bold statement and show off your features. But with so many options available, it can be hard to know which one is right for you.AUPH. Buyout / ShortSquueze. This jumped from $22 to $28 at 3:54 pm Friday on rumor of BMY buying them out. No news over the weekend . The short interest is 17 percent. Thinking even without a confirmed buyout, shorts may be stuck. Good luck if you trade it.Nov 24, 2023 · Short interest in Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) saw shorts transact 17.28 million shares and set a 9.89 days time to cover. Analysts on Wall Street suggest a consensus price target of $13.21, implying an increase of 29.75% to the stock’s recent value. Mission Statement. The mission of ShortSqueeze® is to provide short interest stock market data and services, so our members will be better informed of short selling in the market, track short interest in stocks, and gain from the advantages of this powerful market data. Tuesday November 28, 2023. 20 Min Delayed.Aurinia Pharmaceuticals Inc AUPH shares are trading higher, adding to gains of more than 17% over the last week. The stock has been trending higher since the company announced that its ...WebAUPH fails-to-deliver data, short interest, short sale transactions, short volume, borrow rates, short shares availability and much more information. Help Login Register Trading System Live Account. Ticker: ... AUPH. Trading System Performance for AUPH. Appeared in Fisher Transform Cross Up screen on 2023-02-17 2023-02-08: Short Sale Restricted ...

Short interest for Aurinia Pharmaceuticals gives investors a sense of the degree to which investors are betting on the decline of Aurinia Pharmaceuticals's stock. Short interest data is...

Still, when we talk about a small-cap biotech that is clearly drawing the interest of some big pharma guys, we can say that AUPH's current valuation is very low, without but surely with buyout ...

Shares were able to rally from the lows to a high of $19.87 in February 2023 on a short squeeze. The 25.86% short interest caused the bounces to move in double-digit percentages on a short squeeze, keeping the bears on their toes. CVNA shares short squeezed over 300%, rising from 6.33 on Jan. 27 to $19.87 on Feb. 2.WebNov 2, 2023 · Interest income was $4.5 million at September 30, 2023 versus $1.5 million for the prior year period. Interest income was $12.4 million and $2.2 million for the nine months ended September 30 ... How AI Chat Will Make Money (Outside Of Ads): APIs, plugins, data licensing, and subscriptions may supplement advertising — or supplant it — in the chatbot business model.Web22 votes, 16 comments. 1K subscribers in the AUPH community. A place to discuss Aurinia Pharmaceuticals, Inc.Aurinia Pharmaceuticals Reports First Quarter 2023 Financial and Operational Results Business Wire - Thu May 4, 5:00AM CDT. Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (Aurinia or the Company) today issued its financial results for first quarter ended March 31, 2023. Amounts are expressed in U.S. dollars. 9.28. Aug 3, 2023 · Some thoughts on AUPH: 1. As cited, AUPH reported Lupkynis sales +46% YOY, +20% over Q1, and raised full year guidance to $150 million - $160 million, but admittedly is only scratching the surface ... 2023-03-10 Short sale volume (not short interest) for $AUPH is 38%. http://shortvolumes.com/?t=AUPH $AEZS 37% $REGN 56% $XLV 46%. 11 Mar 2023 12:54:01WebWe would like to show you a description here but the site won’t allow us.For fiscal 2023, the company expects LUPKYNIS revenue to be between $120 million and $140 million, representing annual growth of 15.4% to 34.6% in terms of net product sales. While analysts expect ...

Aurinia ( AUPH) shares have climbed ~59.7% in the year so far despite a ~2% decline over the past 30 days. The stock has added ~5.8% in the post-market with ~1.5M shares changing hands compared to ...Short interest is the volume of POINT Biopharma Global shares that have been sold short but have not yet been covered or closed out. As of October 31st, traders have sold 4,390,000 shares of PNT short. 5.09% of POINT Biopharma Global's shares are currently sold short. Learn More on POINT Biopharma Global's current short interest.Aurinia Pharmaceuticals posted its second quarter numbers on August 3rd. The company posted a GAAP loss of 8 cents a share, more than a dime a share better than expectations. Revenues rose 47% on ...Instagram:https://instagram. target affirmwebull margin account day tradingklip stock dividendhow much is a quarter from 1776 worth Shares were able to rally from the lows to a high of $19.87 in February 2023 on a short squeeze. The 25.86% short interest caused the bounces to move in double-digit percentages on a short squeeze, keeping the bears on their toes. CVNA shares short squeezed over 300%, rising from 6.33 on Jan. 27 to $19.87 on Feb. 2.Web dbefvalue of xbox 360 Aurinia Pharmaceuticals Inc. is a late stage biopharmaceutical company. It focuses on the development of therapeutic immunomodulating drug candidate. The company's lead drug includes Voclosporin ... what is a dividend aristocrat AUPH has multiple downside risks that investors need to consider when managing their position. First, Aurinia is still recording losses and reported a net loss of $82.1M for the first three ...Short interest, stock short squeeze, short interest ratio & short selling data positions for NASDAQ, NYSE & AMEX stocks to find shorts in the stock market.WebMarket Capitalization. $1.24 billion. P/E Ratio. N/A. Dividend Yield. N/A. Price Target. $14.00. Stock Analysis Analyst Forecasts Chart Competitors Earnings Financials Headlines Insider Trades Options Chain Ownership SEC Filings Short Interest Social Media.